Christine Ambrose

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in B-Cell Immunology. Top assignees: Biogen Idec Ma Inc., Apoxis S.a., Biogen Ma Inc.. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Ambrose. Retrieved from https://idiyas.com/inventor/christine-ambrose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 47.1

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 223(Granted Patents)

Company Filing History:

Topotarget Switzerland Sa

patents

where one patent can have more than one assignee

Years Active: 2005-2019

Loading Chart...

Areas of Expertise:

BCMA Polypeptide

Autoimmune Diseases

BAFF Receptor

B-Cell Cancer

Immunological Disorders

Truncated Receptors

BAFF Antibodies

Chimeric Proteins

Tumor Treatment

Nucleic Acids

BAFF Inhibitors

Polypeptides

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10494416 - Methods of modulating immune responses using BCMA polypeptide (2019-12-03),

2. 9650430 - Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) (2017-05-16),

3. 8828669 - Methods of screening for a compound that inhibits the interaction between BAFF and BCMA (2014-09-09),

4. 8821883 - Method of treating B cell cancers by administering truncated BAFF receptors (2014-09-02),

5. 8524672 - Method for inhibiting BAFF-R activity (2013-09-03),

6. 8303958 - Method of treating immunological disorders by administering truncated BAFF receptors (2012-11-06),

7. 8026072 - Method of identifying compounds that bind BAFF-R (2011-09-27),

8. 8022182 - Truncated BAFF receptors (2011-09-20),

9. 7709220 - Methods of monitoring treatment of BAFF-R related disease (2010-05-04),

10. 7700317 - Truncated baff receptors (2010-04-20),

11. 7638327 - BAFF receptor antibodies and methods (2009-12-29),

12. 7635677 - BAFF receptor polypeptides (2009-12-22),

13. 7276241 - Methods of treating a tumor that expresses APRIL by administering BCMA (2007-10-02),

14. 7112421 - Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto (2006-09-26),

15. 7083785 - Methods of treatment by administering an anti-BCMA antibody (2006-08-01),

Title: The Innovative Journey of Christine Ambrose

Introduction: Christine Ambrose, a pioneering inventor hailing from Reading, MA, has made significant contributions to the world of technology and innovation with her groundbreaking ideas and inventions.

Latest Patents: Christine Ambrose holds several patents in the field of renewable energy technologies, including a solar-powered water purification system and a wind energy storage solution.

Career Highlights: With a background in mechanical engineering, Christine Ambrose has worked for over two decades in the renewable energy sector, focusing on developing sustainable solutions to address environmental challenges.

Collaborations: Throughout her career, Christine Ambrose has collaborated with leading research institutions and universities to further her innovative projects, fostering a culture of creativity and forward thinking in the industry.

Conclusion: Christine Ambrose's dedication to creating sustainable technologies and her passion for innovation continue to inspire the next generation of inventors and engineers, leaving a lasting impact on the field of renewable energy.

Profile summary based on public USPTO records.